Allogeneic Stem Cell Transplant Overview

 

High-dose chemotherapy and allogeneic bone marrow or blood stem cell transplantation is a treatment strategy that uses the administration of high doses of anticancer drugs and/or radiation therapy for the purpose of killing cancer cells and transplantation of stem cells to "rescue" or restore bone marrow blood and immune cell production. Transplantation is the term for transfer of tissue (a graft) from one person to another. Allogeneic is the term for a tissue graft from one person to another.

There are many types of allogeneic grafts that can be transplanted from one person to another, including skin, heart, kidney, liver, etc. However, the easiest organ in the body to transplant is the bone marrow. This is because a small quantity of stem cells taken from the bone marrow or peripheral blood of one person can repopulate the entire bone marrow organ of another person. In contrast to other types of transplants, the donor does not "miss" the small amount of bone marrow stem cells removed. A small quantity of bone marrow contains stem cells that are capable of dividing rapidly and repopulating the entire blood and immune system of another person within a short period of time.

High-dose chemotherapy and allogeneic stem cell transplantation is a component of an overall treatment strategy used to treat many kinds of cancer. High-dose chemotherapy and allogeneic stem cell transplantation may be appropriately used as the initial or subsequent treatment, depending on the type of cancer. It is not a treatment of last resort. The role of stem cell transplantation in the management of a specific cancer should be carefully planned following an initial diagnosis of cancer. To learn more about allogeneic stem cell transplantation and the role it may play in the treatment of your cancer, select one of the following.

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Cancer News
US consumers want tougher probe of engineered salmon

February 8, 2012 — WASHINGTON (Reuters) - Three U.S. consumer groups petitioned the Food and Drug Administration on Tuesday to subject a new genetically engineered salmon to a more rigorous review process than is now in place before the fish can be approved as safe to eat.

Spanking kids can cause long-term harm: Canada study

February 7, 2012 — TORONTO (Reuters) - Spanking children can cause long-term developmental damage and may even lower a child's IQ, according to a new Canadian analysis that seeks to shift the ethical debate over corporal punishment into the medical sphere.

Breast cancer kills older women more often

February 7, 2012 — NEW YORK (Reuters Health) - Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease.

Select news items provided by Reuters Health